Next report date
Report period
Q2 2024
EPS estimate
−0.04USD
Revenue estimate
21.96 MUSD
−0.62USD
−23.85 MUSD
81.42 MUSD
19.10 M
About THERATECHNOLOGIES INC
Sector
CEO
Paul Lévesque
Headquarters
Montréal
Website
Employees (FY)
114
Founded
1993
FIGI
BBG000BT60N1
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
$THTX is gonna fall todayPupm&Dump trading strategy idea.
$THTX is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $3.90;
stop-loss — $4.60;
take-profit — $2.50;
Do not view th
SORT1+ Technology is Effective in Many Treatment-Resistant CanceNew Data Show Theratechnologies’ SORT1+ Technology is Effective in Many Treatment-Resistant Cancers
Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptor
Curcumin shows increased anticancer activity when con
Round 2? Similar Breakout Pattern $THWe are seeing a very similar pattern to the one we saw just a month ago. Increased volume on the break, 20 RSI remaining bullish above the 50 line and crossing above the 10MA, MACD moving toward bullish crossover. 200MA and 100MA moving up steadily, short term GMMA consolidating with price and now t
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of THTX is 1.30 USD — it has decreased by 4.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Theratechnologies Inc. stocks are traded under the ticker THTX.
Theratechnologies Inc. is going to release the next earnings report on Jul 11, 2024. Keep track of upcoming events with our Earnings Calendar.
THTX stock is 5.02% volatile and has beta coefficient of 0.01. Check out the list of the most volatile stocks — is Theratechnologies Inc. there?
THTX earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.31 USD resulting in a 73.91% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Theratechnologies Inc. earnings.
Theratechnologies Inc. revenue for the last quarter amounts to 23.45 M USD despite the estimated figure of 23.27 M USD. In the next quarter revenue is expected to reach 20.09 M USD.
Yes, you can track Theratechnologies Inc. financials in yearly and quarterly reports right on TradingView.
THTX stock has fallen by 1.10% compared to the previous week, the month change is a 2.99% fall, over the last year Theratechnologies Inc. has showed a 63.89% decrease.
THTX net income for the last quarter is −4.44 M USD, while the quarter before that showed −2.77 M USD of net income which accounts for −60.00% change. Track more Theratechnologies Inc. financial stats to get the full picture.
Today Theratechnologies Inc. has the market capitalization of 31.89 M, it has increased by 3.19% over the last week.
No, THTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, THTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Theratechnologies Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 114.00 employees. See our rating of the largest employees — is Theratechnologies Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Theratechnologies Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Theratechnologies Inc. stock shows the sell signal. See more of Theratechnologies Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Theratechnologies Inc. future price: according to them, THTX price has a max estimate of 5.85 USD and a min estimate of 3.00 USD. Read a more detailed Theratechnologies Inc. forecast: see what analysts think of Theratechnologies Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Theratechnologies Inc. EBITDA is −3.05 M USD, and current EBITDA margin is −7.20%. See more stats in Theratechnologies Inc. financial statements.